Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd is an international specialty pharma company. The Company manufactures and markets pharmaceuticals formulations as branded generics, as well as generics in India, the United States (US) and several other markets across the world.
The Company’s business is divided into four segments: Indian Branded Generics, US Generics, International Branded Generics (ROW) and Active Pharmaceutical Ingredients (API).
Its brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory. It makes specialty APIs, including peptides, steroids, hormones and anticancers. APIs and Dosage forms are made at 20 plants across India, Israel, the US, Canada, Hungary, Brazil, Mexico and Bangladesh. Its API products include Acamprosate Calcium, Alendronate Sodium, Amifostine trihydrate, Budensonide and Carvedilol.
In September 2010, it acquired Taro Pharmaceutical industries Ltd.
Source: http://www.sunpharma.com/
Sun Pharma: Leveraging its generic market capabilities
| 1983 | Commenced operations in Kolkata |
| 1987 | Nationwide marketing operations rolled out |
| 1995 | Built the first API plant |
| 2004 | First international acquisition: Niche Brand in the US |
| 2012 | Acquired controlling stake in Taro and full control on Caraco |
Updated: August, 2013